Immunomodulatory Effects of Clinically Used Fat Emulsion to Promote Angiogenesis and Osteogenesis for Bone Repair
Materials · 24.03.2026 · 19 (7) · 1290
DOI: 10.3390/ma19071290 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials, online erschienen am 24.03.2026. Verfasst von Luyao Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Southern University of Science and Technology, Shenzhen 518055, China. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Shenzhen Science and Technology Program.
Abstract (Originalsprache)
Bone defects have become a leading cause of disability and mortality. The pro-inflammatory state and impaired vascularization are major factors hindering bone defect repair. However, current bone regeneration materials lack the ability to regulate the osteoimmune microenvironment and promote vascularized bone regeneration. In this study, we employed clinically used fat emulsion (FE), which is intravenously administered to provide nutrition and energy for patients, to investigate the effect of immunomodulation on promoting angiogenesis and osteogenesis. Results from RT-qPCR analysis and immunofluorescence staining demonstrated that FE exhibited potent anti-inflammatory effects by reducing the expression of the pro-inflammatory marker inducible nitric oxide synthase (iNOS) and upregulating the expression of the anti-inflammatory marker transforming growth factor-beta (TGF-β). Endothelial tube formation and scratch assays demonstrated that FE promoted angiogenesis and cell migration by releasing vascular endothelial growth factor (VEGF) within the inflammatory microenvironment. Alkaline phosphatase (ALP) and alizarin red S (ARS) staining revealed that FE facilitated ALP activity and calcium nodule formation by releasing bone morphogenetic protein-2 (BMP-2) within the inflammatory microenvironment. These findings may prove promising and cost-effective for the clinical treatment of bone defects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Biomedical Engineering, Southern University of Science and Technology, Shenzhen 518055, China.
- College of Medical Engineering, Shenzhen University of Advanced Technology, Shenzhen 518055, China.
- Centre for Translational Medicine Research & Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
- School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou 511442, China.
- National Innovation Center for Advanced Medical Devices, Shenzhen 518131, China.
- Department of Bone & Joint Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China.
ORCID-Profile: Yuxiao Lai, Wei Zhang
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Shenzhen Science and Technology Program
- China Postdoctoral Science Foundation
- Postdoctoral Fellowship Program of CPSF
Zitieren
APA
Cheng, L., Wang, Z., Liu, Y., Zhang, Y., Gao, Y., Zhou, T., Lai, Y., & Zhang, W. (2026). Immunomodulatory Effects of Clinically Used Fat Emulsion to Promote Angiogenesis and Osteogenesis for Bone Repair. Materials, 19(7), 1290. https://doi.org/10.3390/ma19071290
Vancouver
Cheng L, Wang Z, Liu Y, Zhang Y, Gao Y, Zhou T, et al. Immunomodulatory Effects of Clinically Used Fat Emulsion to Promote Angiogenesis and Osteogenesis for Bone Repair. Materials. 2026;19(7):1290. doi:10.3390/ma19071290
BibTeX
@article{Cheng2026,
author = {Cheng, Luyao and Wang, Zetao and Liu, Yujie and Zhang, Yuyang and Gao, Yu and Zhou, Tianyi and Lai, Yuxiao and Zhang, Wei},
title = {Immunomodulatory Effects of Clinically Used Fat Emulsion to Promote Angiogenesis and Osteogenesis for Bone Repair},
journal = {Materials},
year = {2026},
volume = {19},
number = {7},
pages = {1290},
doi = {10.3390/ma19071290}
}
EUVIMED